Pi Network has launched Protocol 28 on its testnet, following the successful Protocol 27 upgrade on the mainnet, with the mainnet upgrade scheduled for October 16, 2026. This upgrade aims to improve transaction data handling and empower developers to upgrade smart-contract groups. Despite this technical progress, Pi's price remains stuck between low and mid Bollinger Bands, showing bearish momentum with heavy short-selling and low trading volumes compared to peers. The price faces resistance at $0.09 and risks dropping to $0.0767 if support at $0.085 fails, indicating cautious market sentiment ahead of the upgrade.
Pi Coin price dynamics provide context for readers following cryptocurrency developments. For readers following crypto markets, here is Pluang's market snapshot as of Oct 06, 2026 01:32 WIB: Among 50 major cryptocurrencies priced on Pluang, 25 rose and 24 fell today. Notable movers include EOS at Rp12.649 with an 8.13% increase and a typical hold time of 87 days, Cardano (ADA) at Rp4.732 with a 6.77% rise and Pluang order activity showing 40% Sell / 60% Buy, and Filecoin (FIL) at Rp19.598 with a 6.30% gain and 80% Buy order activity. This data reflects varied market sentiment across major coins on the platform.
BNP Paribas Exane raised NVIDIA's price target from $285 to $345 due to strong demand for its AI chips, signaling potential upside of about 45.6% from the current price. NVIDIA shares have gained about 25% in 2026, driven by growth in AI infrastructu...
Raymond James increased its price target for SBA Communications to $271 from $264, signaling a 68.6% upside from the current share price of $160.74. The growth is driven by rising mobile data demand, network expansions by wireless carriers, and stead...
Antimony Resources Corp. has closed a flow-through financing, issuing over 10.6 million shares at $0.47 each, raising $5 million to fund exploration and development of its Bald Hill Antimony Project in New Brunswick, Canada. Bald Hill is noted as the...
NVIDIA stock reached a new all-time high, rising 28% year to date, driven by strong AI demand signals, including Foxconn's record revenue month attributed to AI product growth. Taiwan Semiconductor and Broadcom shares also rose, supporting the bullis...
Novavax shares surged 22% following Sanofi's rollout of the Nuvaxovid COVID-19 vaccine for the fall season, giving Novavax a commercial boost through its licensing deal. Unlike Moderna and BioNTech, Novavax earns royalties from Sanofi's sales rather ...
